PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

Bijan Salehizadeh - Retatrutide, Peptides, Hims vs Ro, and Lilly's War on Compounded GLP-1s

Patient storyHims House3,037 views1:00:30Aug 2026

Our summary

A patient reviews the program. It has no captions we could read, so this is drawn from its title and description.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Sponsor: Superpower
  2. 1:16 No one knows anything about Heidi Overton (FDA nominee)
  3. 6:29 Eli Lilly's war on 503A pharmacies
  4. 8:47 The Lilly "grand bargain"
  5. 13:49 When compounding becomes a "new drug"
  6. 17:34 Branded drugs crush margins
  7. 21:51 Hims management scorecard
  8. 26:29 Retatrutide reclassification fight

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
retatrutide
Who is speaking
Patient

Find more like it

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV